Results 141 to 150 of about 4,151 (165)

Dutasteride/spironolactone

Reactions Weekly, 2023
openaire   +1 more source

Dutasteride/tamsulosin

Reactions Weekly, 2023
openaire   +2 more sources

Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia

European Urology, 2004
Jack Barkin, Mario Reis, TEUVO L J Tammela   +2 more
exaly  

Photosensitivity associated with dutasteride therapy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020
Martina, Espasandín-Arias, Sara, García-Rodiño, José-Manuel, Suárez-Peñaranda, María-Teresa, Rodríguez-Granados   +3 more
openaire   +2 more sources

Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)

BJU International, 2011
J Curtis Nickel, Peter J Gilling, TEUVO L J Tammela   +2 more
exaly  

Usefulness of prostate‐specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study

BJU International, 2012
Stephen J Freedland, Mark Emberton, Curtis Pettaway   +2 more
exaly  

Dutasteride

2016
openaire   +1 more source

The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT Study

Journal of Urology, 2008
Claus G Roehrborn, Paul Siami, Jack Barkin   +2 more
exaly  

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Lancet, The, 2012
Blair Egerdie, Gregg Eure, Libby Black   +2 more
exaly  

<p>The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis</p>

Clinical Interventions in Aging, 2019
Zhongbao Zhou, Zhenli Gao, Jitao Wu
exaly